AU2002238855A1 - N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same - Google Patents

N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same

Info

Publication number
AU2002238855A1
AU2002238855A1 AU2002238855A AU2002238855A AU2002238855A1 AU 2002238855 A1 AU2002238855 A1 AU 2002238855A1 AU 2002238855 A AU2002238855 A AU 2002238855A AU 2002238855 A AU2002238855 A AU 2002238855A AU 2002238855 A1 AU2002238855 A1 AU 2002238855A1
Authority
AU
Australia
Prior art keywords
compound
processes
producing
active ingredient
phenylarylsulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002238855A
Other versions
AU2002238855B2 (en
Inventor
Shinsuke Hashimoto
Kaoru Kobayashi
Takayuki Maruyama
Atsushi Naganawa
Yoshihiko Nakai
Tetsuji Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority claimed from PCT/JP2002/002245 external-priority patent/WO2002072564A1/en
Publication of AU2002238855A1 publication Critical patent/AU2002238855A1/en
Application granted granted Critical
Publication of AU2002238855B2 publication Critical patent/AU2002238855B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002238855A 2001-03-12 2002-03-11 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same Ceased AU2002238855B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2001068498 2001-03-12
JP2001-68498 2001-03-12
JP2001281569 2001-09-17
JP2001-281569 2001-09-17
JP2002-7760 2002-01-16
JP2002007760 2002-01-16
PCT/JP2002/002245 WO2002072564A1 (en) 2001-03-12 2002-03-11 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same

Publications (2)

Publication Number Publication Date
AU2002238855A1 true AU2002238855A1 (en) 2003-03-20
AU2002238855B2 AU2002238855B2 (en) 2007-12-06

Family

ID=27346214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002238855A Ceased AU2002238855B2 (en) 2001-03-12 2002-03-11 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same

Country Status (24)

Country Link
US (3) US7235667B2 (en)
EP (2) EP1369419B1 (en)
JP (3) JP3555620B2 (en)
KR (1) KR100886854B1 (en)
CN (1) CN1294126C (en)
AT (2) ATE522513T1 (en)
AU (1) AU2002238855B2 (en)
BR (1) BR0208027A (en)
CA (1) CA2439604C (en)
CZ (1) CZ304035B6 (en)
DE (1) DE60220255T2 (en)
DK (2) DK1612208T3 (en)
ES (1) ES2286230T3 (en)
HU (1) HU230056B1 (en)
IL (2) IL157701A0 (en)
MX (1) MXPA03008134A (en)
NO (1) NO329682B1 (en)
NZ (1) NZ528120A (en)
PL (1) PL218750B1 (en)
PT (2) PT1369419E (en)
RU (1) RU2299202C2 (en)
TW (1) TWI317359B (en)
WO (1) WO2002072564A1 (en)
ZA (1) ZA200306884B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264388A1 (en) * 2002-09-09 2004-03-29 Ono Pharmaceutical Co., Ltd. Process for producing 4-methyl-1,3-thiazol-2-ylsulfonyl halide
PT1603893E (en) * 2003-01-29 2008-08-21 Asterand Uk Ltd Ep4 receptor antagonists
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
EP1642594A1 (en) * 2003-06-27 2006-04-05 Ono Pharmaceutical Co., Ltd. Remedy for urinary tract diseases
GB0401334D0 (en) * 2004-01-21 2004-02-25 Novartis Ag Organic compounds
JPWO2006004115A1 (en) * 2004-07-05 2008-04-24 中外製薬株式会社 Overactive bladder treatment
JP2008189549A (en) * 2005-05-12 2008-08-21 Astellas Pharma Inc Carboxylic acid derivative or its salt
JP2009057282A (en) * 2005-12-19 2009-03-19 Astellas Pharma Inc Carboxylic acid derivative or salt thereof
TW200817319A (en) 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
CA2677769C (en) * 2007-02-16 2016-01-19 Ono Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
SI2177512T1 (en) * 2007-08-01 2012-06-29 Taisho Pharmaceutical Co Ltd Inhibitor of binding of s1p1
EP2116618A1 (en) * 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
CA2728511A1 (en) * 2008-06-23 2009-12-30 Astellas Pharma Inc. Sulfonamide compounds or salts thereof
TW201107309A (en) * 2009-07-27 2011-03-01 Kissei Pharmaceutical Indole derivatives, or the pharmaceutically acceptable salts
JP2013532688A (en) 2010-07-26 2013-08-19 ブリストル−マイヤーズ スクイブ カンパニー Sulfonamide compounds useful as CYP17 inhibitors
JP5363636B2 (en) * 2011-10-21 2013-12-11 ファイザー・リミテッド New salts and medical uses
US20140039004A1 (en) * 2012-07-31 2014-02-06 Ono Pharmaceutical Co., Ltd. Method of treating of gastroesophageal reflux disease
JP6103893B2 (en) * 2012-11-15 2017-03-29 サントリー食品インターナショナル株式会社 Coffee oil production method
EP3138633B1 (en) * 2014-04-30 2018-11-21 Industrias Peñalver, S.L. Programmable concentric head for the application of liquid to lids of different shapes
US10227338B2 (en) * 2015-11-13 2019-03-12 Daewoong Pharmaceutical Co., Ltd. Substituted benzenesulfonamides as sodium channel blockers
RU2659955C1 (en) * 2017-10-26 2018-07-04 Галина Ильхамовна Лукина Method for diagnosing high gastroesophageal refluxes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2419923A1 (en) * 1973-04-28 1974-11-28 Fujisawa Pharmaceutical Co SULPHONIC ACID ESTERS, PROCESS FOR THEIR PRODUCTION AND USE AS A CONDENSATION AGENT
JPS5748534B2 (en) 1974-03-04 1982-10-16
DE2555048A1 (en) * 1975-12-06 1977-06-30 Pfersee Chem Fab PROCESS AND DEVICE FOR THE PRODUCTION OF PERMANENT, Aqueous EMULSIONS OF WATER-INSOLUBLE SUBSTANCES
JPS5293469A (en) * 1976-02-02 1977-08-05 Fuji Photo Film Co Ltd Method of curing gelatin
JPH05293469A (en) 1992-04-17 1993-11-09 Toda Constr Co Ltd Production of sterilized and purified water and equipment thereof
TW523506B (en) * 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
AU4431400A (en) * 1999-05-12 2000-12-05 Japan As Represented By President Of National Cancer Center Anticancer agents containing ep1 antagonists as the active ingredient
WO2001008674A1 (en) 1999-07-29 2001-02-08 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives and remedies for allodynia
EP1369129A4 (en) * 2001-03-14 2005-08-03 Ono Pharmaceutical Co Remedies for depression containing ep1 antagonist as the active ingredient

Similar Documents

Publication Publication Date Title
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
MXPA03006648A (en) Anti-thrombotic compounds, production and use thereof as medicaments.
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
AU2002363776A1 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
EP1199076A3 (en) Medicament containing tocotrienol as active component
AU2003284769A1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU2002343729A1 (en) Compound prioritization for drug discovery
AU2003284759A1 (en) Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU2002335354A1 (en) Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
AU2002308369A1 (en) 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
AU2002232239A1 (en) Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
AU2002244962A1 (en) Pyrazolecarboxamide derivative, intermediate therefor, and pest control agent containing the same as active ingredient
MXPA03008636A (en) Isoquinuclidine derivative, process for producing the same, and medicinal composition containing the same.
AU2002355890A1 (en) Active ingredient mixtures
AU2002361987A1 (en) Substituted beta-aminoalcohols used as medicaments